Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guizhou Taihe Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern chemical drugs. Founded in 1992 and based in the Guizhou province, the company leverages regional botanical resources to produce standardized herbal formulations alongside conventional pharmaceuticals. Its therapeutic focus primarily encompasses hepatology, rheumatology, and anti-infectives, with flagship products such as Compound Gantai Granules and Yishen Juanbi Pills. The company operates GMP-certified facilities and is recognized as a high-tech enterprise within its region. Guizhou Taihe Pharmaceutical maintains a robust domestic distribution network, serving the healthcare needs of the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guizhou Taihe Pharmaceutical.